GrantsAtlas
StartupsNonprofits

Intercept Health Fund grants

Funded by Intercept Health Fund

Grants, convertible grants and equity for broad-spectrum preventatives against respiratory viruses, plus delivery platforms for them.

Intercept Health Fund is a 501(c)(3) public charity that funds work aimed at making respiratory infections far less common. Its open call backs broad-spectrum preventatives: a shot, nasal spray, pill or similar product meant to protect against rhinoviruses, influenza, coronaviruses and other respiratory viruses at once. The fund wants to move several candidates that meet its published target product concept through mid-stage clinical trials, and it also supports platforms that deliver these products into the respiratory tract.

Funding can come as a grant, a convertible grant or an equity investment, depending on the project and the applicant. Grants usually carry milestone-based reporting and rights to non-confidential results, while equity follows standard venture terms with a mission license side letter. Indirect costs are capped by a published policy. Applicants at any stage are welcome, from exploratory research through clinical work, and no clinical data is required to apply.

The process starts with a short project overview, and most overviews do not advance to a full proposal. Company founders, academic labs, research institutes and nonprofits anywhere can apply, as long as they are not subject to sanctions or export-control restrictions. Proposals should describe the full product vision in one document rather than splitting it by virus family. The fund has said a separate call for air cleaning technologies will be announced later.

What it funds

  • Broad-spectrum preventatives that protect against several respiratory virus families, such as rhinoviruses, influenza and coronaviruses
  • Priority approaches including broad-spectrum antivirals, broad-spectrum T cell vaccines, trained immunity, next-generation interferon-like molecules and siRNA/ASO antivirals
  • New delivery platforms that get preventatives to the upper and lower respiratory tracts (the only enabling-platform proposals currently accepted)
  • Work at any stage, from exploratory research and preclinical studies through manufacturing and early clinical trials
  • Projects funded through grants, convertible grants or equity investments

Who can apply

  • For-profit companies, including early-stage biotech startups
  • Academic labs and research institutes
  • Nonprofit organizations
  • Applicants in any country, except parties subject to applicable sanctions or export-control restrictions
  • Teams at any development stage; clinical data is not required

How to apply

  1. Read the open call and the fund's target product concept on the Intercept website
  2. Pick the right track: product candidate or delivery platform
  3. Copy the matching Google Doc template and complete your project overview, covering the full product vision with milestones and budget
  4. Submit the overview and any supporting files through the linked Airtable form for that track
  5. If your overview is selected, prepare a full proposal when invited

Intercept Health Fund grants: common questions

Do I need clinical data to apply?

No. The fund says applicants at any stage are eligible, from exploratory research onward, and no clinical data is required.

Is the fund only for nonprofits?

No. For-profit companies, academic labs, research institutes and nonprofits are all eligible, and the fund can make equity investments as well as grants.

Should I send separate proposals for each virus family?

No. The fund asks for one proposal that covers your full broad-spectrum vision, with milestones and budget.

Will the fund sign an NDA?

Not at the overview stage. The fund advises not sharing anything you would not share without an NDA.

Does it fund air purification technology?

A separate call for air cleaning technologies is planned. Until then, the fund asks time-sensitive air cleaning inquiries to go to its team email.

Before you apply

Amounts, eligibility and deadlines change every cycle. Read the current solicitation on the official page before you start an application.

  1. 01Breakthrough Energy Explorer GrantBreakthrough EnergyGrants for early-stage, high-risk climate technology research, typically led by scientists in a university lab or research organization.RollingStartups
  2. 02Parkinson's Disease Therapeutics Pipeline ProgramThe Michael J. Fox Foundation for Parkinson's ResearchThe Michael J. Fox Foundation's flagship program funding preclinical and clinical development of new Parkinson's disease therapies, mainly for companies.RollingStartups
  3. 03Small Business Innovation Research (SBIR)US federal agencies (coordinated by SBA)Federal R&D funding for US small businesses developing technology with commercial potential. Eleven agencies run their own SBIR solicitations.StartupsSmall businesses